CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2023-03-01 | Hashad Mohamed Wa'el Ahmed Chief Executive Officer | Grant or award | +50,000 | 50,000 | ||
| 2023-01-27 | Hare Joshua Chief Scientific Officer | Sale | −20,000 | $4.28 | $86K | 7,793,263 |
| 2023-01-03 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −1,472 | $3.37 | $5K | 147,042 |
| 2023-01-03 | Clavijo James CFO and Treasurer | Shares withheld for taxes | −1,288 | $3.37 | $4K | 75,649 |
| 2022-12-21 | Borger Erin Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Hare Neil E Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Soffer Rock Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Ross Cathy Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Hare Joshua Chief Scientific Officer | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | LOSORDO DOUGLAS W Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Ungaro Ursula Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Soffer Donald M Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-21 | Girolamo Todd C Director | Grant or award · Stock Option (Right to buy) | +5,000 | 5,000 | ||
| 2022-12-02 | Hare Joshua Chief Scientific Officer | Sale | −20,000 | $3.74 | $75K | 7,813,263 |
| 2022-11-16 | Lehr Paul T General Counsel, Secretary | Grant or award · Employee Stock Option (right to buy) | +22,843 | 22,843 | ||
| 2022-11-16 | Hare Joshua Chief Scientific Officer | Grant or award | +48,140 | 7,861,403 | ||
| 2022-10-12 | Hare Joshua Chief Scientific Officer | Sale | −100,000 | $3.61 | $361K | 7,813,263 |
| 2022-10-03 | Clavijo James CFO and Treasurer | Shares withheld for taxes | −1,256 | $3.75 | $5K | 76,937 |
| 2022-10-03 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −1,435 | $3.75 | $5K | 148,514 |
Page 11 of 14 · 271 trades